Hsu, C.-M.; Yang, M.-Y.; Tsai, M.-S.; Chang, G.-H.; Yang, Y.-H.; Tsai, Y.-T.; Wu, C.-Y.; Chang, S.-F.
Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas. Int. J. Mol. Sci. 2021, 22, 8881.
https://doi.org/10.3390/ijms22168881
AMA Style
Hsu C-M, Yang M-Y, Tsai M-S, Chang G-H, Yang Y-H, Tsai Y-T, Wu C-Y, Chang S-F.
Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas. International Journal of Molecular Sciences. 2021; 22(16):8881.
https://doi.org/10.3390/ijms22168881
Chicago/Turabian Style
Hsu, Cheng-Ming, Ming-Yu Yang, Ming-Shao Tsai, Geng-He Chang, Yao-Hsu Yang, Yao-Te Tsai, Ching-Yuan Wu, and Shun-Fu Chang.
2021. "Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas" International Journal of Molecular Sciences 22, no. 16: 8881.
https://doi.org/10.3390/ijms22168881
APA Style
Hsu, C.-M., Yang, M.-Y., Tsai, M.-S., Chang, G.-H., Yang, Y.-H., Tsai, Y.-T., Wu, C.-Y., & Chang, S.-F.
(2021). Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas. International Journal of Molecular Sciences, 22(16), 8881.
https://doi.org/10.3390/ijms22168881
